Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity - Nature Nanotechnology
www.nature.com
Cytokine interleukin-12 (IL-12) has potential for tumour suppression yet off-target effects limit potential applications. Here the authors report on the delivery of IL-12 mRNA encapsulated in extracellular vesicles to lungs via inhalation and demonstrate the immunotherapeutic potential of targeted cytokine mRNA therapy.
  • ganksy@lemmy.worldEnglish
    11·
    4 months ago

    I think all headlines should highlight the costs and benefits of the subject.